Can a daily pill calm severe eczema from the inside?
Disease control
Not yet recruiting
This phase 2 trial tests whether an oral drug called EC-18 can reduce the severity of moderate to severe atopic dermatitis, a chronic inflammatory skin condition. About 150 adults aged 19 to under 80 will take either EC-18 or a placebo once daily for 16 weeks. Researchers will me…
Phase 2 • Sponsor: Enzychem Lifesciences Corporation • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC